Boston Children’s Hospital together with Washington University and the University of North Carolina, are launching the new IDDRC-CTSA Brain Gene Registry. The registry will harness the power of genomic data acquired during clinical care to better understand the relationship between rare gene variants and neurodevelopment, an essential step as we move towards understanding mechanisms and developing therapies for intellectual disability and autism.

Dr. Fagiolini receives a LouLou Foundation CDKL5 Pilot Grant award for her research project: “ASO therapy in CDKL5 deficiency disorder”